Inhibikase Therapeutics Inc (IKT)
1.46
-0.13
(-8.18%)
USD |
NASDAQ |
Apr 30, 16:00
1.485
+0.02
(+1.71%)
After-Hours: 20:00
Inhibikase Therapeutics Price: 1.46 for April 30, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 30, 2024 | 1.54 | 1.595 | 1.43 | 1.46 | 55031.00 |
Apr 29, 2024 | 1.65 | 1.78 | 1.59 | 1.59 | 40442.00 |
Apr 26, 2024 | 1.67 | 1.82 | 1.67 | 1.71 | 98983.00 |
Apr 25, 2024 | 1.82 | 1.90 | 1.712 | 1.90 | 21668.00 |
Apr 24, 2024 | 1.63 | 1.87 | 1.543 | 1.87 | 62249.00 |
Apr 23, 2024 | 1.44 | 1.61 | 1.42 | 1.58 | 79090.00 |
Apr 22, 2024 | 1.96 | 1.96 | 1.29 | 1.37 | 369205.0 |
Apr 19, 2024 | 2.12 | 2.13 | 2.02 | 2.04 | 52727.00 |
Apr 18, 2024 | 2.102 | 2.15 | 2.044 | 2.10 | 27638.00 |
Apr 17, 2024 | 2.20 | 2.20 | 2.11 | 2.13 | 37008.00 |
Apr 16, 2024 | 2.298 | 2.30 | 2.126 | 2.126 | 13062.00 |
Apr 15, 2024 | 2.19 | 2.25 | 2.145 | 2.195 | 27860.00 |
Apr 12, 2024 | 2.18 | 2.23 | 2.15 | 2.19 | 31387.00 |
Apr 11, 2024 | 2.15 | 2.25 | 2.15 | 2.25 | 24626.00 |
Apr 10, 2024 | 2.09 | 2.20 | 2.09 | 2.15 | 28755.00 |
Apr 09, 2024 | 2.18 | 2.20 | 2.05 | 2.13 | 24120.00 |
Apr 08, 2024 | 2.17 | 2.29 | 2.15 | 2.21 | 34846.00 |
Apr 05, 2024 | 2.18 | 2.27 | 2.150 | 2.20 | 42011.00 |
Apr 04, 2024 | 2.20 | 2.270 | 2.15 | 2.20 | 52105.00 |
Apr 03, 2024 | 2.13 | 2.28 | 2.09 | 2.15 | 26545.00 |
Apr 02, 2024 | 2.15 | 2.290 | 2.12 | 2.15 | 46473.00 |
Apr 01, 2024 | 2.20 | 2.28 | 2.01 | 2.16 | 67763.00 |
Mar 28, 2024 | 2.18 | 2.445 | 2.08 | 2.16 | 97891.00 |
Mar 27, 2024 | 2.26 | 2.318 | 2.25 | 2.30 | 15216.00 |
Mar 26, 2024 | 2.21 | 2.39 | 2.21 | 2.29 | 41020.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.81
Minimum
Oct 09 2023
59.40
Maximum
Dec 23 2020
10.12
Average
5.078
Median
Price Benchmarks
Tenax Therapeutics Inc | 3.90 |
BioRestorative Therapies Inc | 1.42 |
Bio-Path Holdings Inc | 2.83 |
ADMA Biologics Inc | 6.52 |
Hepion Pharmaceuticals Inc | 1.365 |
Price Related Metrics
Price to Book Value | 0.8733 |
Earnings Yield | -244.5% |
Market Cap | 9.588M |